The result demonstrated the inhibitory effect of HERC2 on anti-tumor immunity, as indicated by impaired activation of CD8+ T cells, CD4+ T cells, and NK cells in the coculture system of PBMCs with HERC2-overexpressed HCC cells. The gene discussed is CD8A; the disease is hepatocellular carcinoma.